Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|March 16, 2019
Myeloid-Derived Suppressor Cells in SepsisIrene T Schrijver, Charlotte Théroude, Thierry Roger
Frontiers in Immunology|August 22, 2022
Modes of action and diagnostic value of miRNAs in sepsisNikolaos Antonakos, Charly Gilbert, Charlotte Théroude, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 28, 2021
Macrophage migration inhibitory factor promotes the migration of dendritic cells through CD74 and the activation of the Src/PI3K/myosin II pathwayAnnette Ives, Didier Le Roy, Charlotte Théroude, et al.
Frontiers in Immunology|December 6, 2018
Sirtuin 5 Deficiency Does Not Compromise Innate Immune Responses to Bacterial InfectionsTytti Heinonen, Eleonora Ciarlo, Charlotte Théroude, et al.
The Journal of Infectious Diseases|January 1, 2020
Trained Immunity Confers Broad-Spectrum Protection Against Bacterial InfectionsEleonora Ciarlo, Tytti Heinonen, Charlotte Théroude, et al.
Intensive Care Medicine Experimental|February 11, 2022
High levels of monocytic myeloid-derived suppressor cells are associated with favorable outcome in patients with pneumonia and sepsis with multi-organ failureIrene T Schrijver, Eleni Karakike, Charlotte Théroude, et al.
Frontiers in Immunology|October 4, 2021
Trained Immunity Confers Prolonged Protection From ListeriosisCharlotte Théroude, Marta Reverte, Tytti Heinonen, et al.
Frontiers in Immunology|September 13, 2017
Sirtuin 2 Deficiency Increases Bacterial Phagocytosis by Macrophages and Protects from Chronic Staphylococcal InfectionEleonora Ciarlo, Tytti Heinonen, Charlotte Théroude, et al.
European Journal of Immunology|June 10, 2022
COVID-19 rapidly increases MDSCs and prolongs innate immune dysfunctionsIrene T Schrijver, Charlotte Théroude, Nikolaos Antonakos, et al.
Cells|February 23, 2024
Myeloid-Derived Suppressor-like Cells as a Prognostic Marker in Critically Ill Patients: Insights from Experimental Endotoxemia and Intensive Care PatientsIrene T Schrijver, Jacobus Herderschee, Charlotte Théroude, et al.
Pageof 1